UTMD

Utah Medical Products, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-27

Figures on this page computed 2026-11-08 12:56 UTC

Last close

72.42USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-27

20.8xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-27
The filing itself
26.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
The filing itself
29.3%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
37.2%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-K for 2025, filed 2026-03-27
The filing itself
0.004Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
- 10-K for 2025, filed 2026-03-27
- 10-Q for 2025, filed 2026-08-12
The filing itself
1.7%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2026-03-27

Growth is the furthest below its sector's middle: 0.28 against 0.47 on the market's range.

All from 100

lens 2 of 9

Sales

98.0

2016-12-31 to 2025-12-31100 at the start98.0

Sales: 100.00 on 2016-12-31 to 98.02 on 2025-12-31, down 2%.

Profit

93.1

2016-12-31 to 2025-12-31100 at the start93.1

Profit: 100.00 on 2016-12-31 to 93.06 on 2025-12-31, down 7%.

Shares in issue

86.0

2016-12-31 to 2025-12-31100 at the start86.0

Shares in issue: 100.00 on 2016-12-31 to 86.03 on 2025-12-31, down 14%.

Sales is at 98, Profit is at 93, Shares in issue is at 86, against 100 in 2016.

Sales is at 98, Profit is at 93, Shares in issue is at 86, against 100 in 2016.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-27

Sales, where the first year is 10098
Source
filed
Statement
income
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
The filing itself
Profit, where the first year is 10093
Source
filed
Statement
income
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
The filing itself
Shares in issue, where the first year is 10086
Source
filed
Statement
income
Fiscal year
2025
Accession
0001096906-26-000395
Reported in
USD
The filing itself